Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (151-160 of 365) with videos related to

Pageof 37
Sort By:
Prostaglandins|December 1, 1976
The effect of reported prostaglandin synthetase inhibitors on estradiol-stimulated uterine prostaglandin biosynthesis in vivo in the ovariectomized ratV C Jordan, V D Castracane
Molecular Carcinogenesis|November 1, 1996
Design of an ideal hormone replacement therapy for womenD A Tonetti, V C Jordan
Cancer Research|August 1, 1997
MCF-7: the first hormone-responsive breast cancer cell lineA S Levenson, V C Jordan
Pharmacology & Therapeutics|January 1, 1984
The pharmacology and clinical uses of tamoxifenB J Furr, V C Jordan
Biochemical Pharmacology|August 1, 1985
Metabolism of tamoxifen and its uterotrophic activityS D Lyman, V C Jordan
Cancer Surveys|January 1, 1992
A molecular strategy to control tamoxifen resistant breast cancerS Y Jiang, V C Jordan
Cancer Research|April 1, 1989
Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouseS P Robinson, V C Jordan
The Surgical Clinics of North America|October 1, 1990
Adjuvant antiestrogen therapy for breast cancer. Past, present, and futureD F Gibson, V C Jordan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Endometrial carcinoma and tamoxifen: clearing up a controversyV C Jordan, V J Assikis
Molecular Medicine Today|May 1, 1996
Targeted anti-estrogens to treat and prevent diseases in womenD A Tonetti, V C Jordan
Pageof 37

Showing results (151-160 of 365) with videos related to

Sort By:
Pageof 37
Prostaglandins|December 1, 1976
The effect of reported prostaglandin synthetase inhibitors on estradiol-stimulated uterine prostaglandin biosynthesis in vivo in the ovariectomized ratV C Jordan, V D Castracane
Molecular Carcinogenesis|November 1, 1996
Design of an ideal hormone replacement therapy for womenD A Tonetti, V C Jordan
Cancer Research|August 1, 1997
MCF-7: the first hormone-responsive breast cancer cell lineA S Levenson, V C Jordan
Pharmacology & Therapeutics|January 1, 1984
The pharmacology and clinical uses of tamoxifenB J Furr, V C Jordan
Biochemical Pharmacology|August 1, 1985
Metabolism of tamoxifen and its uterotrophic activityS D Lyman, V C Jordan
Cancer Surveys|January 1, 1992
A molecular strategy to control tamoxifen resistant breast cancerS Y Jiang, V C Jordan
Cancer Research|April 1, 1989
Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouseS P Robinson, V C Jordan
The Surgical Clinics of North America|October 1, 1990
Adjuvant antiestrogen therapy for breast cancer. Past, present, and futureD F Gibson, V C Jordan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Endometrial carcinoma and tamoxifen: clearing up a controversyV C Jordan, V J Assikis
Molecular Medicine Today|May 1, 1996
Targeted anti-estrogens to treat and prevent diseases in womenD A Tonetti, V C Jordan
Pageof 37